Abstract
Thiourea analogs 1–20 were synthesized and evaluated for their in vitro β-glucuronidase inhibitory potential. The compounds 9 (0.86 ± 0.01 μM), 6 (1.24 ± 0.01 μM), 16 (1.64 ± 0.02 μM) and 15 (2.12 ± 0.02 μM) showed potent activity. Other analogs 1–5, 7, 8, 10, 11, 13, 17, 20 showed better activity than standard drug d-saccharic acid 1,4-lactone (47.34 ± 0.21 μM) ranging 4.36–34.4 μM. All synthetic compounds were characterized by different spectroscopic methods. This study has identified a new class of potent inhibitors β-glucuronidase.
Similar content being viewed by others
References
Ahmad S, Hughes MA, Yeh LA, Scott JE (2012) Potential repurposing of known drugs as potent bacterial β-glucuronidase inhibitors. J Biomol Screen 17:957–965
Ala JP, DeLoskey RJ, Huston EE, Jadhav PK, Lam PYS, Eyermann CJ, Hodge CN, Schadt MC, Lewandowski FA, Weber PC, McCabe DD, Duke JL, Chang CH (1998) Molecular recognition of cyclic urea HIV-1 protease inhibitors. J Biol Chem 273:12325–12331
Anouar EH, Raweh S, Bayach I, Taha M, Baharudin MS, Meo FD, Hasan MH, Adam A, Ismail NH, Weber JF, Trouillas P (2013) Antioxidant properties of phenolic Schiff bases: structure-activity relationship and mechanism of action. J Comput Aided Mol Des 27:951–964
Aziz AN, Taha M, Ismail NH, Anouar EH, Yousuf S, Jamil W, Awang K, Ahmat N, Khan KM, Kashif SM (2014) Synthesis, crystal structure, DFT studies and evaluation of the antioxidant activity of 3,4-Dimethoxybenzenamine schiff bases. Molecules 19:8414–8433
Bäckbro K, Löwgren S, Österlund K, Atepo J, Unge T (1997) Unexpected binding mode of a cyclic sulfamide HIV-1 protease inhibitor. J Med Chem 40:898–902
Bank N, Bailine SH (1965) Urinary β-glucuronidase activity in patients with urinary-tract infection. N Engl J Med 272:70–75
Bloom JD, Dushin RG, Curran KJ, Donahue F, Norton EB, Terefenko E, Jonas TR, Ross AA, Feld B, Lang SA, Grandi D (2004) Bioorgan Med Chem 14:3401–3406
Boyland E, Gasson JE, Williams DC (1957) Enzyme activity in relation to cancer; the urinary β-glucuronidase activity of patients suffering from malignant disease. Br J Cancer 11:120–129
Caygill JC, Pitkeathly DA (1966) A study of β-acetylglucosaminase and acid phosphatase in pathological joint fluids. Ann Rheum Dis 25:137–144
Cheng TC, Chuang KH, Roffler SR, Cheng KW, Leu YL, Chuang CH, Huang CC, Kao CH, Hsieh YC, Chang LS, Cheng TL, Chen CS (2015) Discovery of specific inhibitors for intestinal E. coli β-Glucuronidase through in silico virtual screening. Sci World J 2015:740815. doi:10.1155/2015/740815
Chrusciel RA, Strohbach JW (2004) Non-peptidic HIV protease inhibitors. Curr Top Med Chem 4:1097–1114
Flieger J, Żelazko AC, Rządkowska M, Szacoń E, Matosiuk D (2012) Usefulness of reversed-phase HPLC enriched with room temperature imidazolium based ionic liquids for lipophilicity determination of the newly synthesized analgesic active urea derivatives. J Pharm Biomed Anal 66:58–67
Fortin JS, Lacroix J, Desjardins M (2007) N-Phenyl-N′-(2-chloroethyl)urea analogs of combretastatin A-4: is the N-phenyl-N′-(2-chloroethyl)urea pharmacophore mimicking the trimethoxy phenyl moiety. Bioorgan Med Chem 15:4456–4469
Fortin S, Wei L, Moreau E, Labrie P, Petitclerc É, Kotra LP, Gaudreault RC (2009) Mechanism of action of N-phenyl-N′-(2-chloroethyl)ureas in the colchicine-binding site at the interface between α- and β-tubulin. Bioorgan Med Chem 17:3690–3697
Gonick HC, Kramer HJ, Schapiro AE (1973) Urinary β-glucuronidase activity in renal disease. Arch Intern Med 132:63–69
Holešová S, Valášková M, Hlaváč D, Madejová J, Samlíková M, Tokarský J, Pazdziora E (2014) Antibacterial kaolinite/urea/chlorhexidine nanocomposites: experiment and molecular modeling. Appl Surf Sci 305:783–791
Hultén J, Bonham NM, Nillroth U, Hansson T, Zuccarello G, Bouzide A, Åqvist J, Classon B, Danielson HA, Karlén Kvarnstrom I, Samuelsson B, Hallberg A (1997) Cyclic HIV-1 protease inhibitors derived from mannitol: synthesis, inhibitory potencies, and computational predictions of binding affinities. J Med Chem 40:885–889
Jamil W, Perveen S, Shah SAA, Taha M, Ismail NH, Perveen S, Ambreen N, Khan KM, Choudhary MI (2014) Phenoxyacetohydrazide schiff bases: β-Glucuronidase inhibitors. Molecules 19:8788–8802
Kallet HA, Lapco L (1967) Urine β-glucuronidase activity in urinary tract disease. J Urol 97:352–356
Khan KM, Ali M, Taha M, Perveen S, Choudhary MI, Voelter W (2008) An expedient and selective approach towards disulfides using sodium bromate/sodium hydrogen sulfite reagent. Lett Org Chem 5:432–434
Khan KM, Taha M, Ali M, Perveen S (2009) A mild and alternative approach towards symmetrical disulfides using H3IO5/NaHSO3 combination. Lett Org Chem 6:319–320
Khan KM, Taha M, Rahim F, Ali M, Jamil W, Perveen S, Choudhary MI (2010) An improved method for the synthesis of disulfides by periodic acid and sodium hydrogen sulfite in water. Lett Org Chem 7:244
Khan KM, Taha M, Naz F, Khan M, Rahim F, Samreen Perveen S, Choudhary MI (2011) Synthesis and in vitro leishmanicidal activity of disulfide derivatives. Med Chem 7:704–710
Khan KM, Taha M, Naz F, Ali S, Perveen S, Choudhary MI (2012) Acylhydrazide schiff bases: DPPH radical and superoxide anion scavengers. Med Chem 8:705–710
Khan KM, Naz F, Taha M, Khan A, Perveen S, Choudhary MI, Voelter W (2014a) Synthesis and in vitro urease inhibitory activity of N, N’-disubsituted thioureas. Eur J Med Chem 74:314–323
Khan KM, Rahim F, Wadood A, Taha M, Khan M, Naureen S, Ambreen N, Hussain S, Perveen S, Choudhary MI (2014b) Evaluation of bisindole as potent β-Glucuronidase inhibitors: synthesis and in silico based studies. Bioorgan Med Chem Lett 24:1825–1829
Khan KM, Saad SM, Shaikh NN, Hussain S, Fakhri MI, Perveen S, Taha M, Choudhary MI (2014c) Synthesis and β-glucuronidase inhibitory activity of 2-arylquinazolin-4(3H)-ones. Bioorgan Med Chem 22:3449–3454
Khan KM, Ambreen N, Taha M, Halim SA, Zaheer-ul-Haq Naureen S, Rasheed S, Perveen S, Ali S, Choudhary MI (2014d) Structure-based design, synthesis and biological evaluation of β-Glucuronidase inhibitors. J Comput Aided Mol Des 28:577–585
Lee J, Kang M, Shin M, Kim JM, Kang SU, Lim JO, Choi HK (2003) N-(3-acyloxy-2-benzylpropyl)-N’-[4-(methylsulfonylamino)benzyl]thiourea analogs: novel potent and high affinity antagonists and partial antagonists of the vanilloid receptor. J Med Chem 46:3116–3126
Liu Z, Wang Y, Lin H, Zuo D, Wang L, Zhao Y, Gong P (2014) Design, synthesis and biological evaluation of novel thieno[3,2-d]pyrimidine derivatives containing diaryl urea moiety as potent antitumor agents. Eur J Med Chem 85:215–227
Musharraf SG, Bibi A, Shahid N, Najam-ul-Haq M, Khan M, Taha M, Mughal UR, Khan KM (2012) Acylhydrazide and isatin schiff bases as alternate UV laser desorption ionization (LDI) matrices for low molecular weight (LMW) peptides analysis. Am J Anal Chem 3:779–789
Plum CM (1967) β-glucoronidase activity in serum, cerebrospinal fluid and urine in normal subjects and in neurological and mental patients. Enzymol Biol Clin 8:97–112
Rahim F, Ullah K, Ullah H, Wadood A, Taha M, Rehman AU, Uddin I, Ashraf M, Shaukat A, Rehman W, Hussain S, Khan KM (2015) Triazinoindole analogs as potent inhibitors of α-glucosidase: synthesis, biological evaluation and molecular docking studies. Bioorg Chem 58:81–87
Reddy BS (1976) Dietary factors and cancer of the large bowel. Semin Oncol 3:351–359
Roberts AP, Frampton J, Karim SM, Beard RW (1967) Estimation of β-glucoronidase activity in urinary-tract infection. N Engl J Med 276:1468–1470
Ronald AR, Silverblatt F, Clark H, Cutler RE, Turck M (1971) Failure of urinary β-glucuronidase activity to localize the site of urinary tract infection. Appl Environ Microbiol 21:990–992
Santos LD, Lima LA, Cechinel-Filho V, Corrêa R, Buzzi FC, Nunes RJ (2008) Synthesis of new 1-phenyl-3-{4-[(2E)-3-phenylprop-enoyl]phenyl}-thiourea and urea derivatives with antinociceptive activity. Bioorgan Med Chem 16:8526–8534
Schapiro A, Paul W, Gonick H (1968) Urinary β-glucuronidase in urologic diseases of the kidneys. J Urol 100:146–157
Seth PP, Ranken R, Robinson DE, Osgood SA, Risen LM, Rodgers EL, Migawa MT, Jefferson EA, Swayze EE (2004) Aryl urea analogs with broad-spectrum antibacterial activity. Bioorgan Med Chem 14:5569–5572
Sham HL, Zhao C, Marsh KC, Betebenner DA (1996a) Novel azacyclic ureas that are potent inhibitors of HIV-1 protease. J Biochem Biophys Res Commun 225:436–440
Sham HL, Zhao C, Stewart KD, Betebenner DA, Lin S (1996b) A novel, picomolar inhibitor of human immunodeficiency virus type 1 protease. J Med Chem 39:392–397
Sivan SK, Vangala R, Manga V (2013) Molecular docking guided structure based design of symmetrical N, N′-disubstituted urea/thiourea as HIV-1 gp120–CD4 binding inhibitors. Bioorgan Med Chem 21:4591–4599
Sperker B, Backman JT, Kromer K (1997) The role of β-glucuronidase in drug disposition and drug targeting in humans. Clin Pharm 33:18–31
Taha M, Ismail NH, Jamil W, Yousuf S, Jaafar FM, Ali MI, Kashif SM, Hussain E (2013) Synthesis, evaluation of antioxidant activity and crystal structure of 2,4-Dimethylbenzoylhydrazones. Molecules 18:10912–10929
Taha M, Naz H, Rasheed S, Ismail NH, Rahman AA, Yousuf S, Choudhary MI (2014) Synthesis of 4-Methoxybenzoylhydrazones and evaluation of their antiglycation activity. Molecules 19:1286–1301
Taha M, Ismail NH, Lalani S, Fatmi MQ, Atiahab Siddiqui S, Khan KM, Imran S, Choudhary MI (2015a) Synthesis of novel inhibitors of α-glucosidase based on the benzothiazole skeleton containing benzohydrazide moiety and their molecular docking studies. Eur J Med Chem 92:387–400
Taha M, Ismail NH, Baharudin MS, Lalani S, Mehboob S, Khan KM, Yousuf S, Siddiqui S, Rahim F, Choudhary MI (2015b) Synthesis crystal structure of 2-methoxybenzoylhydrazones and evaluation of their a-glucosidase and urease inhibition potential. Med Chem Res 24:1310–1324
Venkatachalam TK, Mao C, Uckun FM (2004) Effect of stereochemistry on the anti-HIV activity of chiral thiourea compounds. Bioorgan Med Chem 12:4275–4284
Watson RJ, Allen DR, Birch HL, Chapman GA, Gayle A, Knight LA, Oliver K, Owen DA, Thomas EJ, Tremayne N, Williams SC (2008) Development of CXCR3 antagonists. Part 3: tropenyl and homotropenyl-piperidine urea derivatives. Bioorgan Med Chem Lett 18:147–151
Yang W, Liu H, Li M, Wang F, Zhou W, Fan J (2012) Synthesis, structures and antibacterial activities of benzoylthiourea derivatives and their complexes with cobalt. J Inorg Biochem 116:97–105
Zhao C, Sham HL, Sun M, Stoll VS, Stewart KD, Lin S, Mo H (2005) Synthesis and activity of N-acyl azacyclic urea HIV-1 protease inhibitors. Bioorgan Med Chem Lett 15:549–555
Acknowledgments
Authors would like to acknowledge The Ministry of Agriculture (MOA) Malaysia and Universiti Teknologi MARA under MOA Grant File No. 100-RMI/MOA 16/6/2 (1/2013) and Higher Education Commission (HEC) Pakistan, under National Research Program for Universities (Project No. 20-1910) for the financial support.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Taha, M., Ismail, N.H., Jamil, W. et al. Synthesis and evaluation of unsymmetrical heterocyclic thioureas as potent β-glucuronidase inhibitors. Med Chem Res 24, 3166–3173 (2015). https://doi.org/10.1007/s00044-015-1369-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00044-015-1369-x